• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[溴隐亭治疗催乳素瘤引起的形态学变化]

[Morphological changes in prolactinoma induced by bromocriptine treatment].

作者信息

Scanarini M

机构信息

Divisione di Neurochirurgia, Complesso Convenzionato, Ospedale-Università di Padova.

出版信息

Minerva Endocrinol. 1990 Jan-Mar;15(1):13-5.

PMID:2274009
Abstract

The structural modifications to PRL-secreting pituitary adenomas induced by medical treatment with bromocryptine are described. Whereas the consistency of the tumour diminishes after a shgort period of treatment, making surgical removal easier, it increases after a long period (years) owing to interstitial fibrosis phenomena that impede surgical removal.

摘要

描述了用溴隐亭药物治疗对分泌催乳素的垂体腺瘤所引起的结构改变。在短期治疗后肿瘤的质地变软，使手术切除更容易，但在长期（数年）治疗后，由于间质纤维化现象阻碍手术切除，肿瘤质地又会变硬。

相似文献

1
[Morphological changes in prolactinoma induced by bromocriptine treatment].[溴隐亭治疗催乳素瘤引起的形态学变化]
Minerva Endocrinol. 1990 Jan-Mar;15(1):13-5.
2
[Clinical aspects, morphology and biology of prolactinomas after therapy with dopamine agonists. A review of the literature].
Pathologe. 1992 Jul;13(4):183-9.
3
[Treatment of hypophyseal prolactin-secreting macroadenomas].[垂体催乳素分泌型大腺瘤的治疗]
Recenti Prog Med. 1989 Sep;80(9):471-3.
4
Light microscopical morphometry of prolactin secreting adenomas under treatment with dopamine agonists.多巴胺激动剂治疗下催乳素分泌性腺瘤的光学显微镜形态计量学
Histol Histopathol. 1987 Apr;2(2):135-42.
5
Changes in prolactinomas and somatotropinomas in humans treated with bromocriptine.溴隐亭治疗的人类催乳素瘤和生长激素瘤的变化。
Pathol Res Pract. 1988 Sep;183(5):580-3. doi: 10.1016/S0344-0338(88)80015-3.
6
Growth of prolactinoma despite lowering of serum prolactin by bromocriptine.尽管溴隐亭使血清催乳素水平降低，但泌乳素瘤仍在生长。
Neurosurgery. 1989 Mar;24(3):417-23. doi: 10.1227/00006123-198903000-00020.
7
Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.泌乳素瘤的临床与组织学相关性，特别提及对溴隐亭的耐药性。
Acta Neurochir (Wien). 2005 Jul;147(7):751-7; discussion 757-8. doi: 10.1007/s00701-005-0498-2. Epub 2005 Mar 14.
8
Giant prolactinomas: clinical management and long-term follow up.巨大泌乳素瘤：临床管理与长期随访
J Neurosurg. 2002 Aug;97(2):299-306. doi: 10.3171/jns.2002.97.2.0299.
9
Management of prolactin-secreting pituitary adenomas.催乳素分泌型垂体腺瘤的管理
West J Med. 1990 Nov;153(5):546-7.
10
[Treatment of macroprolactinomas with delayed bromocriptine. Effectiveness of a single intramuscular injection].[用溴隐亭延迟治疗大泌乳素瘤。单次肌内注射的有效性]
Med Clin (Barc). 1990 Feb 3;94(4):126-9.

引用本文的文献

1
Commentary: "Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery".评论：“泌乳素瘤：经蝶窦手术后早期缓解的预后因素”
Front Endocrinol (Lausanne). 2021 May 14;12:695498. doi: 10.3389/fendo.2021.695498. eCollection 2021.
2
Discrimination of prolactinoma from hyperprolactinemic non-functioning adenoma.泌乳素瘤与高泌乳素血症无功能性腺瘤的鉴别诊断。
Endocrine. 2010 Feb;37(1):140-7. doi: 10.1007/s12020-009-9279-7. Epub 2009 Nov 14.
3
Effect of dopaminergic drug treatment on surgical findings in prolactinomas.
多巴胺能药物治疗对泌乳素瘤手术结果的影响。
Pituitary. 2011 Mar;14(1):68-74. doi: 10.1007/s11102-010-0261-4.